Evaluating the Cost-Effectiveness of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in the Treatment of Patients with Insulin-Treated Type 2 Diabetes in Australia

Key Points

• RT-CGM demonstrated significant cost-effectiveness by improving patient outcomes and reducing costs, particularly in subgroups with insulin-treated diabetes.
• Findings indicate that real-time continuous glucose monitoring may enhance glycemic management, leading to overall better health for patients.
• Assessment involved evaluating outcomes related to blood glucose management in different demographic populations, focusing on Indigenous Australians and younger individuals.
• Potential implications include advocating for broader reimbursement policies based on the cost-effectiveness of glucose monitoring technologies.